BioCentury
ARTICLE | Clinical News

Sareum preclinical data

February 21, 2011 8:00 AM UTC

In an animal model of AML, no detectable cancer was found in 2 of 10 animals treated with Sareum's inhibitor of aurora kinases and FMS-like tyrosine kinase 3 (FLT3; CD135) at 6 weeks post-treatment...